[1] 李可,朱大伟,陈建昆, 等.子痫前期发病机制与临床治疗研究进展[J].解放军医学杂志,2019,44(5):423-429. [2] Campbell N, Lamarca B, Cunningham MJ. The role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathophysiology of preeclampsia[J]. Curr Pharm Biotechnol,2018,19(10):781-785. [3] 李敏清,黄星,陈军.VCAM-1和TNF-α在重度子痫前期合并胎儿生长受限孕妇母血及脐血中的表达[J].广西医科大学学报,2012,29(6):857-859. [4] 谢幸, 孔北华,段涛. 妇产科学[M].第9版. 北京:人民卫生出版社, 2018:84. [5] 徐金良,张宁芝,梅莉.早发型重度子痫前期患者不同终止妊娠时机的母婴结局分析[J].中国计划生育学杂志,2019,27(9):1201-1204. [6] 胡洪兰,刘应芬,曾祟亮.sEng、sFIt-1及AT1-AA在子痫前期患者中的表达及诊断价值[J].检验医学与临床,2017,14(10):1426-1428. [7] Liu F, Yang L, Zheng Y, et al. Effects and molecular mechanisms of AT1-AA in retinopathy of preeclampsia[J]. Acta Biochim Biophys Sin (Shanghai),2019,51(1):51-58. [8] Faulkner JL, Amaral LM, Cornelius DC, et al. Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension[J]. Am J Physiol Regul Integr Comp Physiol,2017,312(1):R125-R131. [9] Siddiqui AH, Irani RA, Blackwell SC, et al. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity[J]. Hypertension,2010,55(2):386-393. [10] 赵先兰,刘传,刘彩.孕妇外周血、脐血和胎盘组织中AT1-AA及内皮素1的表达及其与子痫前期发病的关系[J].中华妇产科杂志,2012,47(10):721-725. [11] Zhang S, Zheng R, Yang L, et al. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction[J]. J Cell Physiol,2013,228(1):142-148. [12] Cunningham MJ, Castillo J, Ibrahim T, et al. AT1-AA (angiotensin II type 1 receptor agonistic autoantibody) blockade prevents preeclamptic symptoms in placental ischemic rats[J]. Hypertension,2018,71(5):886-893. [13] Thakoordeen S, Moodley J, Naicker T. Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and -2 in HIV associated preeclampsia[J]. Hypertens Pregnancy,2017,36(2):168-174. [14] Kim TK, Park CS, Na HJ, et al. Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFalpha-induced angiogenesis[J]. Exp Mol Med,2017,49(2):e294. [15] Chen W, Zhang Y, Yue C, et al. Accumulation of advanced glycation end products involved in inflammation and contributing to severe preeclampsia, in maternal blood, umbilical blood and placental tissues[J]. Gynecol Obstet Invest,2017,82(4):388-397. [16] Rios D, Alpoim PN, Godoi LC, et al. Increased levels of sENG and sVCAM-1 and decreased levels of VEGF in severepreeclampsia[J]. Am J Hypertens,2016,29(11):1307-1310.
2020, Vol. 27 
